Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...
A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...
In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...
China: A new study published in the International Journal of General Medicine highlighted the potential role of serum cholinesterase (ChE) levels as a biomarker for assessing prognosis in ovarian ...
CERo Therapeutics (CERO) presented preclinical results of lead compound CER-1236 in ovarian cancer during the 2025 SITC Spring Scientific ...
Presentation of encouraging preclinical results for CER-1236 in ovarian cancer, indicating potential ... assessment of clinical and anatomic pathology after CER-1236 infusion showed T cell ...
Based on the NCCN guidelines, treatment selection for ovarian cancer is primarily determined by the histologic subtype, stage of disease, and whether the patient is a candidate for primary surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback